期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 272, 期 1-2, 页码 161-171出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2003.12.023
关键词
9-nitrocamptothecin; Caco-2 cells; P-glycoprotein; intestinal transport; everted gut sacs
The intestinal absorptive characteristics and the efflux mechanisms of 9-nitrocamptothecin (9-NC), a novel water-insoluble camptothecin (CPT) derivative, were investigated. The Caco-2 cells and the everted gut sacs were used as models of the intestinal mucosa to assess transepithelial transport of 9-NC. The determination of 9-NC was performed by HPLC. In the Caco-2 cells, the absorptive transport of 9-NC was pH dependent and the transport was enhanced at weakly acidic pH on the apical side. No concentration dependence and saturation were observed for the absorptive transport of 9-NC at concentrations up to 250 muM, while secretory transport were concentration dependent and saturable process (K-m was 49.8 +/- 1.2 muM, V-max was 38.28 +/- 0.8ng/cm(2)/min). In the presence of verapamil (100 muM) and CsA (10 muM), potent inhibitors of P-glyprotein (P-gp)/MRP2 (cMOAT), the PappBL-AP/PappAP-BL ratio was decreased from 3.4 to 1.4 and 1.3, respectively, and permeation of apical to basolateral was enhanced approximately two-fold. In the everted gut sacs, the absorption of 9-NC was passive diffusion and had no significant difference in different gut regions. Adding verapamil in the everted gut sacs over a concentration ranging from 10 to 100 muM, the absorption of 9-NC was significantly enhanced, especially more markedly in lower small intestine (P < 0.05). Overall, the current study suggests that pH and efflux transporters are capable of mediating the absorption and efflux of 9-NC, and they may play significant roles in limiting the oral absorption of 9-NC. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据